Condition: Cannabis Use Disorder · Sponsor: Johns Hopkins University
This pilot study will evaluate the therapeutic potential of psilocybin in people with Cannabis Use Disorder (CUD). This study will examine the impact of psilocybin treatment on cannabis use and related variables in 12 people with CUD. This is an open-label proof-of-concept trial in which participants will complete a 12-week course of study treatment including two psilocybin sessions with psychological support, and follow-up assessments 3 and 6 months after the first psilocybin session.
This description comes directly from the study's public registry record.
Ian Geithner, MPS · 410-550-1972 · igeithn1@jhmi.edu
Albert Garcia-Romeu, PhD · agarci33@jhmi.edu
Always discuss trial participation with your own doctor first.
| Johns Hopkins Center for Psychedelic and Consciousness Research | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06660381